Article
Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.
British journal of cancer - 22 Nov 2011
Thomas F, Motsinger-Reif A A, Hoskins J M, Dvorak A, Roy S, Alyasiri A, Myerson R J, Fleshman J W, Tan B R, McLeod H L
Abstract excerpt
BACKGROUND: There is a large degree of variation in tumour response and host toxicities associated with neoadjuvant chemoradiation for rectal cancer patients. We performed a complimentary pharmacogenetic study to investigate germline polymorphisms of genes involved in 5-fluorouracil (5-FU) and irinotecan pathways and their potential association with clinical outcomes and toxicities from neoadjuvant chemoradiation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
